EANS-News: Annual accounts 2011/2012: Marseille-Kliniken AG improves profitability

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Financial Figures/Balance Sheet

Subtitle: - EBIT with EUR 10.9 million almost doubled - Group income
increases by more than 124% to EUR 6.5 million - Occupancy rate
increased to 88.9%, but still has potential for improvement -
Internal reorganization shall be continued in order to further
strengthen profitability

Hamburg (euro adhoc) - Marseille-Kliniken AG could significantly
improve its results in business year 2011/2012 (1 July 2011 - 30 June
2012). Based on an increase in revenues from EUR 190.0 million
(2010/2011) to EUR 195.1 million EBIT increased from EUR 5.7 million
(2010/2011) to EUR 10.9 million. With a change from EUR 2.9 million
(2010/2011) to EUR 6.5 million group income attributable to
shareholders improved even stronger. In the course of these
developments also the equity ratio increased from 17.1% (2010/2011)
to 19.5%. "Last business year has demonstrated the success of our
strategic reorganization which has been the basis for the improved
earnings and financial power" says Michael Thanheiser, chairman of
Marseille-Kliniken AG.

The turnaround which has already been initiated in the previous
business year has been continued with these results, as the
realignment of the group's strategy is the basis for the improved
cost efficiency. The strategy consists of focusing on the core
business nursing care in the segments inpatient and outpatient,
strengthening of quality leadership and initiation of a decentralized
management structure.

As a result of these measures the company achieved improvements on
all earnings figures. Occupancy rate increased by 1.8 percentage
points to 88.9% at a sales capacity of 7,915 beds. Revenue thereby
increased by 2.7% to EUR 195.1 million. EBITDAR increased by 5.6% to
EUR 54.8 million, EBITDA by 28.5% to EUR 17.6 million and EBIT by
91.2% to EUR 10.9 million. EBIT margin correspondingly improved by
2.6 percentage points to 5.6%. Group income attributable to
shareholders increased by 124% to EUR 6.5 million which causes
earnings per share of EUR 0.45 (previous year: EUR 0.20) based on the
14.46 million outstanding shares. Reasons for this disproportionately
large development were low taxes on income and an almost constant
financial result. Extraordinary items balanced to EUR -0.8 million
caused only a minor effect on the financial accounts.

Operational improvements in business year 2011/2012 were in
particular achieved at facilities which previously had a capacity
utilization below average. By targeted measures the occupancy rates
could be increased at these locations. With the improvements realized
in bed occupancy rate the company however has an average vacancy rate
of more than 10%. Further improvements in this respect will access a
potential on profitability in the future. The general skills shortage
in Germany thereby hinders the company from rapidly improving
capacity utilization. Therefore specific measures for recruitment of
new and binding of existing personnel have been initiated.

The group has recently expanded its management capacities, as firstly
the contract with chairman Michael Thanheiser was prolonged until 31
March 2017 and secondly with Dieter Wopen another member of the
management board was newly appointed starting on 15 November 2012.

Michael Thanheiser comments the existing figures as follows: "We are
pleased with the achieved results as they correspond with our
previously announced expectations. Also the current situation in our
company's operational business confirms our ambition to achieve
continued and sustainable increases in earnings for the future. I am
looking forward for the future collaboration with Dieter Wopen, as
his appointment will further strengthen our competencies for the
nursing care business on management level. We will particularly focus
on the reduction of vacancies and staffing issues against the
background of the existing skills shortage in the German healthcare
sector."

For the current business year 2012/2013 Marseille-Kliniken AG expects
an increase in EBIT and revenues slightly above previous year's
level.

The complete annual report 2011/2012 such as additional shareholders'
information is available for the public in the investor relations
section of the company's website at www.marseille-kliniken.com.

-- End of corporate news --

About Marseille-Kliniken AG:

Marseille-Kliniken AG (ISIN DE0007783003, WKN 778300, MKA) with its
57 residential care facilities, three residential units for assisted
living and about 4,700 employees is a market leading listed company
on health care in Germany. The business model is significantly
influenced by the demographic development. Therefore
Marseille-Kliniken AG has a secured future. Short-term economic
fluctuations on the other hand exert only a minor influence. As a
consistently modern company with strong focus on quality, the private
enterprise is in a good position within a competitive environment
primarily characterized by regionally active charities.

Further inquiry note:
Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 3202791-0
www.marseille-kliniken.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
Hamburg, regulated dealing/prime standard: Frankfurt
language: English